Medicine and Dentistry
Glucagon-Like Peptide-1 Agonist
100%
Blood Pressure
100%
Glucagon Like Peptide 1 Receptor
100%
Diabetes
100%
Chronotherapy
100%
Life
50%
Exenatide
50%
Glucose
50%
Type 2 Diabetes
33%
Maturity Onset Diabetes of the Young
33%
Diabetes Mellitus
33%
Therapeutic Procedure
33%
Food Intake
33%
Gene Oscillation
16%
Nephropathy
16%
Muscle Contractility
16%
Risk Factor for Atherosclerosis
16%
Apoplexy
16%
Retinopathy
16%
Sleep
16%
Rhythm
16%
Anti-Inflammatory Drug
16%
Hypertension
16%
Complication
16%
Elevated Blood Pressure
16%
Smooth Muscle
16%
Semaglutide
16%
Observation
16%
Vascular Smooth Muscle
16%
Signal Transduction
16%
Muscle Cell
16%
Circadian Rhythm
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronotherapy
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Glucagon-Like Peptide 1 Receptor
100%
Exendin 4
50%
Glucose
50%
Diabetes Mellitus
33%
Non Insulin Dependent Diabetes Mellitus
33%
Anti-Inflammatory Drug
16%
Kidney Disease
16%
Elevated Blood Pressure
16%
Complication
16%
Mouse Model
16%
Atherosclerosis
16%
Semaglutide
16%
Hypertension
16%
Retinopathy
16%
Cerebrovascular Accident
16%
Biochemistry, Genetics and Molecular Biology
Blood Pressure
100%
Glucagon-Like Peptide 1 Receptor
100%
Receptor Agonists
75%
Life
37%
Light
25%
Glucose
25%
Experimentation
12%
Gene
12%
Reduction (Chemistry)
12%
Muscle Contractility
12%
Mouse Model
12%
Glucose Level
12%
Sleep
12%
Signal Transduction
12%
Rhythm
12%
Modulation
12%
Training
12%
Circadian Rhythm
12%
Oscillation
12%